Works matching DE "DAPAGLIFLOZIN"

Results: 1160

Diabetic ketoacidosis induced by a sodium–glucose cotransporter-2 inhibitor in a 28-year-old man without known diabetes.

Published in:

Canadian Medical Association Journal (CMAJ), 2025, v. 197, n. 17, p. E478, doi. 10.1503/cmaj.241400

By:

Cho, Seungjae;
Mak, Jessica;
Udell, Jacob A.;
Gold, Wayne L.;
Weisman, Alanna

Publication type:

Article

Effect of dapagliflozin on ventricular repolarization in patients with heart failure with reduced ejection fraction.

Published in:

Heart & Vessels, 2023, v. 38, n. 12, p. 1414, doi. 10.1007/s00380-023-02298-x

By:

Nakase, Masaaki;
Yahagi, Kazuyuki;
Horiuchi, Yu;
Asami, Masahiko;
Yuzawa, Hitomi;
Komiyama, Kota;
Tanaka, Jun;
Aoki, Jiro;
Tanabe, Kengo

Publication type:

Article

Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial).

Published in:

Acta Diabetologica, 2023, v. 60, n. 11, p. 1481, doi. 10.1007/s00592-023-02138-4

By:

Kuchay, Mohammad Shafi;
Khatana, Pushpender;
Mishra, Mitali;
Surendran, Parvathi;
Kaur, Parjeet;
Wasir, Jasjeet Singh;
Gill, Harmandeep Kaur;
Singh, Apanshu;
Jain, Rujul;
Kohli, Chhavi;
Bakshi, Gazal;
Radhika, Vishnupriya;
Saheer, Sumayya;
Singh, Manish Kumar;
Mishra, Sunil Kumar

Publication type:

Article

Perturbations of Telmisartan Alone and in Combination with Ranolazineor Dapagliflozin on the Amplitude and Gating of Voltage-gated Na<sup>+</sup> Current in Neuroblastoma Neuronal Cells.

Published in:

Journal of Physiological Investigation (JPI), 2024, v. 67, n. 3, p. 103, doi. 10.4103/ejpi.EJPI-D-24-00018

By:

Chen, Yi-Jung;
Lee, Chien-Ching;
So, Edmund Cheung

Publication type:

Article

Changes of Pulmonary Microhemodynamics in Experimental Pulmonary Thromboembolism after Pretreatment with K-Channel Activators.

Published in:

Bulletin of Experimental Biology & Medicine, 2022, v. 173, n. 3, p. 302, doi. 10.1007/s10517-022-05538-8

By:

Evlakhov, V. I.;
Poyasov, I. Z.;
Berezina, T. P.

Publication type:

Article

Effect of Dapagliflozin on the Functioning of Rat Liver Mitochondria In Vitro.

Published in:

Bulletin of Experimental Biology & Medicine, 2021, v. 171, n. 5, p. 601, doi. 10.1007/s10517-021-05277-2

By:

Belosludtseva, N. V.;
Starinets, V. S.;
Belosludtsev, K. N.

Publication type:

Article

Flozyny jako jeden z „czterech filarów” terapii niewydolności serca.

Published in:

Heart & Vascular Diseases / Choroby Serca & Naczyn, 2023, v. 20, n. 2/3, p. 92, doi. 10.5603/chsin.97793

By:

Piłat, Patrycja;
Jurkiewicz, Michał;
Krych, Sebastian;
Szyguła-Jurkiewicz, Bożena

Publication type:

Article

Finerenone in SGLT-2 Inhibitors Era: Current Positioning in Diabetic Kidney Disease.

Published in:

Clinical Diabetology, 2022, v. 11, n. 6, p. 357, doi. 10.5603/DK.a2022.0041

By:

Singh, Awadhesh Kumar;
Singh, Ritu;
Shah, Viral N.;
Misra, Anoop

Publication type:

Article

The use of dapagliflozin in the treatment of type 1 diabetes in a 36-year-old patient.

Published in:

Clinical Diabetology, 2021, v. 10, n. 2, p. 200, doi. 10.5603/DK.a2021.0013

By:

Rutkowska, Katarzyna;
Cypryk, Katarzyna

Publication type:

Article

Mathematical Models of the Effect of Glucagon on Glycemia in Individuals With Type 2 Diabetes Treated With Dapagliflozin.

Published in:

Journal of the Endocrine Society, 2024, v. 8, n. 6, p. 1, doi. 10.1210/jendso/bvae067

By:

Yamada, Tomoko;
Sugimoto, Hikaru;
Hironaka, Ken-ichi;
Morita, Yasuko;
Miura, Hiroshi;
Otowa-Suematsu, Natsu;
Okada, Yuko;
Hirota, Yushi;
Sakaguchi, Kazuhiko;
Kuroda, Shinya;
Ogawa, Wataru

Publication type:

Article

Effects of Dapagliflozin on Endothelial Dysfunction in Type 2 Diabetes With Established Ischemic Heart Disease (EDIFIED).

Published in:

Journal of the Endocrine Society, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1210/jendso/bvz017

By:

Zainordin, Nur Aisyah;
Hatta, Sharifah Faradilla Wan Muhamad;
Shah, Fatimah Zaherah Mohamed;
Rahman, Thuhairah Abdul;
Ismail, Nurhuda;
Ismail, Zaliha;
Ghani, Rohana Abdul

Publication type:

Article

Evaluation of toxic effects of dapagliflozin on reproductive system in diabetic rats.

Published in:

Turkish Journal of Medical Sciences, 2022, v. 52, n. 4, p. 1362, doi. 10.55730/1300-0144.5443

By:

ULUS KARACA, Bahar;
BORAN, Tuğçe;
KARAGÖZ KÖROĞLU, Ayça;
ERCAN, Feriha;
ÖZHAN, Gül

Publication type:

Article

Spectrophotometric Absorption Correction Methods for the Estimation of Fixed-Dose Combinations of Dapagliflozin and Metformin Hydrochloride.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2024, v. 58, n. 1, p. 291, doi. 10.5530/ijper.58.1.31

By:

Dalal, Deepak;
Kant, Ravi;
Attri, Kavita;
Sharma, Kiran;
Dhanawat, Meenakshi

Publication type:

Article

New Eco-friendly UV-spectroscopic Methods for Simultaneous Assessment of Dapagliflozin, Saxagliptin and Metformin in Ternary Mixture.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, n. 2, p. 559, doi. 10.5530/ijper.57.2.69

By:

Sen, Dhanya B.;
Jatu, Sohil;
Maheshwari, Rajesh A.;
Zanwar, Aarti Sachin;
Velmurugan, Ramaswamy;
Sen, Ashim Kumar

Publication type:

Article

Development and Validation of a LC-ESI-MS/MS Based Bioanalytical Method for Dapagliflozin and Saxagliptin in Human Plasma.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2018, v. 52, p. S277, doi. 10.5530/ijper.52.4s.108

By:

Goday, Swapna;
Shaik, Abdul Rahaman;
Avula, Prameelarani

Publication type:

Article

RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS CONTAINING DAPAGLIFLOZIN 10 MG UNDER FED CONDITION IN A RANDOMIZED CROSSOVER STUDY IN HEALTHY CAUCASIAN SUBJECTS.

Published in:

Farmacia, 2020, v. 68, n. 1, p. 76, doi. 10.31925/farmacia.2020.1.11

By:

OROIAN, MONICA;
POP, DIANA IOANA;
GHELDIU, ANA-MARIA;
BHARDWAJ, SANDEEP;
MARCOVICI, ADRIANA;
KHUROO, ARSHAD;
VLASE, LAURIAN

Publication type:

Article

AN IMPROVED VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF METFORMIN AND DAPAGLIFLOZIN.

Published in:

International Journal of Chemical & Pharmaceutical Analysis, 2020, v. 7, n. 2, p. 1, doi. 10.21276/ijcpa

By:

Pawar, Amgoth Krishnamanjari;
Babu, Vaddeswaram Ashok;
Harini, Uppada;
Sree, Sindhe Divya

Publication type:

Article

The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction.

Published in:

Pharmacy, 2022, v. 10, n. 6, p. 166, doi. 10.3390/pharmacy10060166

By:

Brust-Sisti, Lindsay;
Rudawsky, Nicole;
Gonzalez, Jimmy;
Brunetti, Luigi

Publication type:

Article

Triple Fixed-dose combination of Dapagliflozin, Sitagliptin, and Metformin for People with Type 2 Diabetes in Indian Settings.

Published in:

Journal of Drug Delivery & Therapeutics, 2024, v. 14, n. 9, p. 66, doi. 10.22270/jddt.v14i9.6692

By:

Dhar, Rajashree;
Prasad, Ashish;
Annadurai, Vivekanandan

Publication type:

Article

The MeViDa Study: Bioequivalence Study of FDC of Dapagliflozin, Vildagliptin SR and Metformin SR in Healthy Indian Volunteers: A Randomized, Open-Label, Crossover Study.

Published in:

Journal of Drug Delivery & Therapeutics, 2024, v. 14, n. 7, p. 1, doi. 10.22270/jddt.v14i7.6674

By:

Pednekar, Abhijit;
Gupta, Amit;
Warrier, Sona

Publication type:

Article

How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area.

Published in:

Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/2018374

By:

Canivell, Silvia;
Mata-Cases, Manel;
Vlacho, Bogdan;
Gratacòs, Mònica;
Real, Jordi;
Mauricio, Dídac;
Franch-Nadal, Josep

Publication type:

Article

Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus.

Published in:

Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/3971060

By:

Mirabelli, Maria;
Chiefari, Eusebio;
Caroleo, Patrizia;
Vero, Raffaella;
Brunetti, Francesco Saverio;
Corigliano, Domenica Maria;
Arcidiacono, Biagio;
Foti, Daniela Patrizia;
Puccio, Luigi;
Brunetti, Antonio

Publication type:

Article

Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience.

Published in:

Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/8501418

By:

Scorsone, Alessandro;
Saura, Gabriella;
Fleres, Mattia;
Spano, Lucia;
Aiello, Vito;
Brancato, Davide;
Di Noto, Anna;
Provenzano, Francesca;
Provenzano, Vincenzo

Publication type:

Article

DELIVER: Extending the benefits of SGLT-2 inhibitors.

Published in:

Global Cardiology Science & Practice, 2023, v. 2023, n. 3, p. 1, doi. 10.21542/gcsp.2023.21

By:

Samaan, Kerollos;
Wagdy, Kerolos

Publication type:

Article

Empagliflozin versus dapagliflozin in heart failure patients – preliminary results from the Dubrava University Hospital Registry.

Published in:

2022

By:

Antolković, Luka;
Pavlov, Marin;
Manola, Šime;
Tomić, Sanda Sokol;
Šerman, Nikola;
Jurin, Ivana

Publication type:

Abstract

Dapagliflozin ameliorates diabetes-induced spermatogenic dysfunction by modulating the adenosine metabolism along the gut microbiota-testis axis.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-51224-2

By:

Jin, Zirun;
Cao, Yalei;
Wen, Qi;
Zhang, Haitao;
Fang, Zhuofan;
Zhao, Qiancheng;
Xi, Yu;
Luo, Zhichao;
Jiang, Hui;
Zhang, Zhe;
Hang, Jing

Publication type:

Article

Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus.

Published in:

2023

By:

Zekry, Rania;
Omran, Gamal A.;
El-Gharbawy, Nashwa M.;
Werida, Rehab H.

Publication type:

Correction Notice

Comparison between an SGLT2 inhibitor and insulin in tumor-to-tissue contrasts in <sup>18</sup>F-FDG PET imaging of diabetic mice.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45094-3

By:

Meidai, Liang;
Yujing, Du;
Zhaoyu, Liu;
Shanshi, Li;
Guangyu, Zhao;
Yan, Fan;
Xiuying, Yang;
Jianhua, Zhang

Publication type:

Article

Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43905-1

By:

Zekry, Rania;
Omran, Gamal A.;
El-Gharbawy, Nashwa M.;
Werida, Rehab H.

Publication type:

Article

Sotagliflozin versus dapagliflozin to improve outcome of patients with diabetes and worsening heart failure: a cost per outcome analysis.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1373314

By:

Weichen Zhang;
Meichen Yu;
Guohua Cheng

Publication type:

Article

Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1357673

By:

Arbel, Ronen;
Azab, Abed N.;
Oberoi, Mansi;
Aboalhasan, Enis;
Star, Artyom;
Elhaj, Khaled;
Khalil, Fouad;
Alnsasra, Hilmi

Publication type:

Article

Effectiveness of dapagliflozin as an insulin adjunct in type 1 diabetes: a semi-mechanistic exposure-response model.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1229255

By:

Sokolov, Victor;
Yakovleva, Tatiana;
Penland, Robert C.;
Boulton, David W.;
Weifeng Tang

Publication type:

Article

Effect of Astragali radix extract on pharmacokinetic behavior of dapagliflozin in healthy and type 2 diabetic rats.

Published in:

Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1214658

By:

Wandi Du;
Jiarong Hu;
Jingru Liang;
Xiaolei Yang;
Boyu Fang;
Guo Ma

Publication type:

Article

Dapagliflozin promotes angiogenesis in hindlimb ischemia mice by inducing M2 macrophage polarization.

Published in:

Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1255904

By:

Heng Yang;
Wanqi Lan;
Wu Liu;
Tingtao Chen;
Yanhua Tang

Publication type:

Article

Dapagliflozin versus empagliflozin in patients with chronic kidney disease.

Published in:

Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1227199

By:

Alnsasra, Hilmi;
Tsaban, Gal;
Solomon, Adam;
Khalil, Fouad;
Aboalhasan, Enis;
Azab, Abed N.;
Azuri, Joseph;
Hammerman, Ariel;
Arbel, Ronen

Publication type:

Article

The proteinuria‐lowering effects of dapagliflozin are associated with an initial decline in estimated glomerular filtration rate in patients with chronic kidney disease.

Published in:

Nephrology, 2023, v. 28, n. 10, p. 540, doi. 10.1111/nep.14207

By:

Murakoshi, Maki;
Kobayashi, Takashi;
Kihara, Masao;
Ueda, Seiji;
Suzuki, Yusuke;
Gohda, Tomohito

Publication type:

Article

A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis.

Published in:

Journal of Diabetes Investigation, 2019, v. 10, n. 4, p. 906, doi. 10.1111/jdi.13090

By:

Hotta, Nigishi

Publication type:

Article

Early administration of dapagliflozin preserves pancreatic β‐cell mass through a legacy effect in a mouse model of type 2 diabetes.

Published in:

Journal of Diabetes Investigation, 2019, v. 10, n. 3, p. 577, doi. 10.1111/jdi.12945

By:

Kanno, Ayumi;
Asahara, Shun‐ichiro;
Kawamura, Mao;
Furubayashi, Ayuko;
Tsuchiya, Shoko;
Suzuki, Emi;
Takai, Tomoko;
Koyanagi‐Kimura, Maki;
Matsuda, Tomokazu;
Okada, Yuko;
Ogawa, Wataru;
Kido, Yoshiaki

Publication type:

Article

Type Disparity in Sodium–Glucose Cotransporter-2 Inhibitors in Incidences of Renal Cell Carcinoma: A Propensity-Score-Matched Cohort Study.

Published in:

Cancers, 2024, v. 16, n. 11, p. 2145, doi. 10.3390/cancers16112145

By:

Lin, Tsung-Kun;
Wang, Wei-Yao;
Yang, Tsung-Yuan;
Jong, Gwo-Ping

Publication type:

Article

Corrigendum.

Published in:: 2016
Publication type:: Correction Notice

Effects of dapagliflozin on blood pressure in hypertensive diabetic patients on renin–angiotensin system blockade.

Published in:

Blood Pressure, 2016, v. 25, n. 2, p. 93, doi. 10.3109/08037051.2015.1116258

By:

Weber, Michael A.;
Mansfield, Traci A.;
Alessi, Federica;
Iqbal, Nayyar;
Parikh, Shamik;
Ptaszynska, Agata

Publication type:

Article

Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis.

Published in:

Clinical Epidemiology, 2023, v. 15, p. 923, doi. 10.2147/CLEP.S418069

By:

Zhou, Guiling;
de Vos, Stijn;
Schuiling-Veninga, Catharina CM;
Bos, Jens;
Rengerink, Katrien Oude;
Pasmooij, Anna Maria Gerdina;
Mol, Peter GM;
de Bock, Geertruida H;
Hak, Eelko

Publication type:

Article

Dapagliflozin mitigates oxidative stress, inflammatory, and histopathological markers of aging in mice.

Published in:

Journal of Medicine & Life, 2024, v. 17, n. 2, p. 157, doi. 10.25122/jml-2023-0343

By:

Shihab, Elaf Mahmood;
Kadhim, Haitham Mahmood;
Shahooth, Samer Salim

Publication type:

Article

Cost-effectiveness analysis of dapagliflozin for people with chronic kidney disease in Malaysia.

Published in:

PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0296067

By:

Lim, Soo Kun;
Lee, Shaun Wen Huey

Publication type:

Article

Role of Metformin Monotherapy Vs Metformin Plus Dapagliflozin in New Onset T2DM Among 40 Plus Obese Women in Glycaemic Control.

Published in:

JK Science, 2024, v. 26, n. 4, p. 209

By:

Singh, Amarjeet;
Badyal, Ashima;
Kotwal, Suman;
Tandon, Vishal R.

Publication type:

Article

Dapagliflozin does not influence arterial stiffness or other bio-markers of arterial ageing in people with type 2 diabetes and kidney disease.

Published in:

Artery Research, 2023, v. 29, n. 1, p. S27, doi. 10.1007/s44200-022-00028-8

By:

Fountoulakis, Nikolaos;
Stathi, Dimitra;
Flaquer, Maria;
Corcillo, Antonella;
Panagiotou, Angeliki;
Mangelis, Anastasios;
Ayis, Salma;
Gnudi, Luigi;
Karalliedde, Janaka

Publication type:

Article

Effect of early treatment with dapagliflozin on the natural history of chronic kidney disease.

Published in:

Nefrologia, 2024, v. 44, n. 3, p. 435, doi. 10.1016/j.nefro.2023.06.009

By:

Marchán-López, Álvaro

Publication type:

Article

Earlier onset of treatment improves the nephroprotective effect of dapagliflozin.

Published in:

Nefrologia, 2024, v. 44, n. 3, p. 431, doi. 10.1016/j.nefro.2023.05.005

By:

Gippini, Antonio;
Prado, Alberto

Publication type:

Article

Acute kidney injury with sodium-glucose co-transporter-2 inhibitors across the cardiovascular and renal outcome trials: Foe or friend?

Published in:

Nefrologia, 2023, v. 43, n. 5, p. 643, doi. 10.1016/j.nefro.2021.05.012

By:

Patoulias, Dimitrios;
Papadopoulos, Christodoulos;
Siskos, Fotios;
Doumas, Michael

Publication type:

Article

Dapagliflozin attenuates cardiac remodeling and dysfunction in rats with β-adrenergic receptor overactivation through restoring calcium handling and suppressing cardiomyocyte apoptosis.

Published in:

Diabetes & Vascular Disease Research, 2023, v. 20, n. 4, p. 1, doi. 10.1177/14791641231197106

By:

Tao Liu;
Jinchun Wu;
Shaobo Shi;
Bo Cui;
Feng Xiong;
Shuang Yang;
Min Yan

Publication type:

Article